✦ LIBER ✦

The Discovery of Orally Active Triaminotriazine Aniline Amides as Inhibitors of p38 MAP Kinase

✍ Scribed by Leftheris, Katerina; Ahmed, Gulzar; Chan, Ran; Dyckman, Alaric J.; Hussain, Zahid; Ho, Kan; Hynes,, John; Letourneau, Jeffrey; Li, Wei; Lin, Shuqun

Book ID: 111867050
Publisher: American Chemical Society
Year: 2004
Tongue: English
Weight: 252 KB
Volume: 47
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm049521d

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery of pyrrolo[2,1-f][1,2,4]triazi

Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitors

✍ Alaric J. Dyckman; Tianle Li; Sidney Pitt; Rosemary Zhang; Ding Ren Shen; Kim W. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 948 KB

SAR of Benzoylpyridines and Benzophenone

SAR of Benzoylpyridines and Benzophenones as p38α MAP Kinase Inhibitors with Oral Activity.

✍ Laszlo Revesz; Ernst Blum; Franco E. Di Padova; Thomas Buhl; Roland Feifel; Herm 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 15 KB 👁 1 views

SAR of benzoylpyridines and benzophenone

SAR of benzoylpyridines and benzophenones as p38α MAP kinase inhibitors with oral activity

✍ Laszlo Revesz; Ernst Blum; Franco E. Di Padova; Thomas Buhl; Roland Feifel; Herm 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 271 KB

5-Cyanopyrimidine Derivatives as a Novel

5-Cyanopyrimidine Derivatives as a Novel Class of Potent, Selective, and Orally Active Inhibitors of p38α MAP Kinase

✍ Liu, Chunjian; Wrobleski, Stephen T.; Lin, James; Ahmed, Gulzar; Metzger, Axel; 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 297 KB

Structure-based virtual screening approa

Structure-based virtual screening approach to the discovery of p38 MAP kinase inhibitors

✍ Hwanho Choi; Ho Jeong Park; Jong Chul Shin; Hyun Sun Ko; Jung Kyun Lee; Soyoung 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 801 KB

ChemInform Abstract: Substituted N-Aryl-

ChemInform Abstract: Substituted N-Aryl-6-pyrimidinones: A New Class of Potent, Selective, and Orally Active p38 MAP Kinase Inhibitors.

✍ Balekudru Devadas; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 22 KB 👁 1 views

## Abstract A series of highly potent and selective p38 MAP kinase inhibitors is developed originating from a substituted N‐aryl‐6‐pyrimidinone scaffold.